NEW YORK (GenomeWeb News) – Molecular diagnostics company Curetis today announced the signing of an exclusive distribution deal with Advanced Technology Company covering the Middle East.
ATC will distribute Curetis' Unyvero solution in the six Gulf Cooperation Council countries and Lebanon. The six GCC countries are Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the United Arab Emirates.
Placement of the Unyvero instruments will begin in the third quarter. The Kuwait Ministry of Health has approved a clinical evaluation project for Unyvero, and Curetis and ATC will "cooperate" with the project.
"At present, no other region in the world has such a rapidly growing demand for improved diagnostics of infectious diseases. At the same time, there is a need to realign and modernize local health-care systems in the Middle East," Curetis CEO Oliver Schacht said in a statement. "With ATC … we have found a very experienced IVD distributor with a strong presence in this exciting market."
Financial and other terms were not disclosed.
Curetis, founded in 2007, is based in Holzgerlingen, Germany and develops products for diagnosing severe infectious diseases. ATC specializes in total medical systems solutions and healthcare services.